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Abstract—The validity of a complex reaction pathway pro-
posed to treat Inflammatory Bowel Disease (IBD) was verified
by a comprehensive time and frequency domain analysis. The
model was taken to the frequency domain to study the effect
and the significance of the negative feedback loop introduced by
the reaction pathways. It could be shown that such proposed
probiotics have very interesting potentials that could be used
extensively in near future.
Index Terms—Synthetic Biology, Control theory, Negative
feedback in Biological systems
I. INTRODUCTION
Inflammatory Bowel Disease (IBD) is characterised by
chronic inflammation of the intestine. The condition is asso-
ciated with an imbalance in immune cell populations, notably
Th17 and Treg. Existing immunosuppressive therapies, when
successful, often elicit systemic side effects and require fre-
quent re-administration. Therefore, the proposed solution is a
probiotic strain that restores the Th17/Treg cell balance via
secretion of IL-10 in response to Nitric oxide in the intestinal
lumen. Overshoot is prevented by an adenine riboswitch-
sRNA construct which responds to extracellular adenosine, an
indicator of the Treg cell population. The two independent
BBSRC, Wellcome Trust, IDT, Eppendorf, BioLab, Snap gene and Oxford
university departments of biochemistry, Engineering and chemistry
reaction pathways - responding separately to IL-10 deficiency
and abundance - and are summarised in Figure 1.
To avoid the complexity of multivariate control systems, the
pathways have been modelled independently. Physiologically,
an elevated serum concentration of NO can be associated
with autoimmunity, whereas an elevated serum adenosine con-
centration can signify immunoinsufficiency. The NO pathway
will be referred to as the ‘negative pathway’, representing
a negative concentration difference in IL-10. Likewise, the
adenosine pathway has been termed the ‘positive pathway’.
Integration of separate stimuli in a dual feedback loop enables
a more dynamic, robust response to the immune state of the
body. Thus the engineered probiotic bacteria would be capable
of maintaining an equilibrium between the Th17 and Treg cell
populations by virtue of the negative feedback system.
A. Negative Pathway
The negative pathway can be modelled in a canonical
manner: nitric oxide triggers oxidation of the SoxR iron-
sulphur cluster, allowing binding to the promoter of IL-10 in
the circuit - pSoxS. This results in transcriptional activation of
the system within approximately 0.01 seconds [1]. Hence, the
system has been modelled by a simple Hill activation function
for IL-10 gene transcription. The SoxR/pSoxS system has been
studied extensively [2] but previous modelling has been limited
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Fig. 1. Simplified schematic diagram of the negative and positive pathways
to that of the SoxR/pSoxS binding interaction by the 2009
Stanford iGEM team [3].
B. Positive Pathway
The positive pathway mechanism facilitates translational in-
hibition of IL-10 to prevent overshoot. The anti-inflammatory
molecule, adenosine, is produced by Treg cells in response to
inflammation, with elevated levels indicating Treg overactivity
and an immunoinsufficient state. Adenosine is subsequently
broken down into ribose and adenine, via an extracytoplasmic,
nucleoside hydrolase, by the engineered cell. Following uptake
into the cell, adenine binds to a riboswitch, resulting in an
increased rate of RNA transcription. A self-splicing ribozyme
separates the riboswitch from the remaining transcript - an
sRNA molecule which is complementary to the 5’ region of
the IL-10 mRNA.
Consequently, translation of IL-10 mRNA is prevented by
the binding of sRNA. It should be noted that NO is an essential
input to the positive pathway and hence, combined model for
both reaction pathways could be found below in Figure‘2.
Fig. 2. Schematic representation of the pathways [4]
II. DYNAMIC MODEL
The dynamic model of both of the pathways were analysed
using the Simbiology toolbox in MATLAB as well as ODE15s
Solver and some of the modelling and parameters are based
on the paper ”Frequency domain analysis of small non-
coding RNAs” [4]. The dynamic time domain analysis of the
system was conducted using the combined model in Figure 2
with different initial conditions corresponding to negative and
positive pathways separately. It is worth mentioning that data
fitting was used to determine some of the parameters. A list of
the parameters and data is available at the end of paper. The
differential equations describing the systems are as follows:
d[sRNA]
dt
= Γ1 − α1[sRNA]− k1[IL-10 mRNA][sRNA], (1)
d[IL-10 mRNA]
dt
= Γ2−α2[IL-10 mRNA]−k1[IL-10 mRNA][sRNA],
(2)
d[IL-10 - i]
dt
= k2[IL-10 mRNA]−α3[IL-10 - i]−k3[IL-10 - i],
(3)
d[IL-10 - s]
dt
= k3[IL-10 - i]− α4[IL-10 - s], (4)
where Γi are the Hill functions describing the rate of tran-
scription with inputs of Adenosine and NO for Γ1 and Γ2
respectively as represented by ui in (5).
Γi =
β[ui]
n
Kn + [ui]n
, (5)
In which β is the maximal transcription factor, K the disso-
ciation coefficient and n the Hill coefficient. k1 is the rate
of sRNA binding to IL-10 mRNA which heavily depends
on the length of the sRNA, making it easy to exploit this
relationship for better control over the fate of the system. k2
is the translation rate of IL-10 mRNA and k3 is the secretion
and diffusion rate of IL-10 [5]. αi represents the dilution +
degradation rate.
It is important to notice that Hill functions introduce non-
linearity into the system as well as sRNA binding. Therefore,
Hill functions have been linearised for transfer function deriva-
tion in the frequency domain, and are noted by γ∗ as follows:
γ∗i = βi
niK
ni
i [ui]
ni−1
(Knii + u
ni
i )
2
, (6)
All the assumptions made for (1) to (4) are listed below:
• Adenosine substituted with adenine as the hydrolase
reaction is believed to be much faster than the body
response
• Concentration of adenine and NO kept constant for dy-
namic analysis due to intra- and extracellular abundance
• The initial conditions used for time domain analysis
correspond to maximal insufficiency based on [6], [7]
and [8].
• Stochastic response ignored due to the large number of
E. Coli used.
A list of all parameters and concentrations used in figures,
charts and graphs can be found at the end of the section.
A. Negative pathway dynamics
Negative pathway dynamics are fully described by the
ODEs stated previously. It should be noted that based on
the second assumption, the level of NO would not change
with time and hence d[NO]dt = 0. An initial concentration of
19.88µM was used for elevated level of NO corresponding
to IL-10 deficiency in patients with IBD [6] as well as the
nominal concentration of 18µM for adenine [8]. The evolution
of the system to NO stimuli is illustrated in Figure 3.
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Fig. 3. NO response dynamics with nominal level of Adenine
As it can be seen from Figure 3, [IL-10] reaches a concen-
tration of 14.16 µM after roughly 180 seconds. It is important
to note that the initial concentration of IL-10 is set to 0
for simplicity, meaning that in reality, the model can correct
deficiencies of IL-10 to a margin of 14.16µM . A control
mechanism is essential in order for the probiotic bacteria to be
able to maintain a healthy level of IL-10. To determine how
system would respond and whether or not it would be able to
stabilise the IL-10 concentration, it is necessary to construct a
large-scale version of the model that incorporates the body as
well as the system embedded in a negative feedback loop [9].
The control modelling is discussed in more detail later in the
paper. Lastly, the model behaviour is as expected due to the
constant production rate, as opposed to the degradation rate,
and hence a bounded steady state value is expected.
B. Positive pathway dynamics
The complexity of the positive pathway is visible from
Figure 2. The complexity of the system was maintained for
the dynamic analysis based on ODEs stated previously. It
should be noted that based on the second assumption, the
concentration of adenine would not change with time and
hence d[Adenine]dt = 0. An initial concentration of 100µM
was used for elevated level of adenine corresponding to IL-10
abundance in patients with IBD [8] as well as the nominal
concentration of 13.24µM for NO [6]. The evolution of the
system to adenine stimuli is illustrated in Figure 4.
It can be observed from Figure 4, that [IL-10] is inhibited
significantly and it could be assumed that a high concentration
of adenine could inhibit translation of IL-10 completely. It
should be noted that the length of sRNA and the promoter
strength in both negative and positive pathways(k1 , β1 , β2)
play a significant role and hence they have been optimised for
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Fig. 4. Adenine response dynamics with nominal level of NO
maximum inhibition as well as maximum translation of IL-
10 in both positive and negative pathways respectively. The
sensitivity analysis and sRNA models are discussed below.
III. SENSITIVITY ANALYSIS AND SRNA MODELLING
Sensitivity analysis was done separately for each reaction
pathway in order to find the most significant steps and pa-
rameters, thus enabling these parameters to be exploited in
order to improve the responsiveness of the system to smaller
perturbations in concentrations. The sensitivity of [IL − 10]
with respect to parameters used in simulations is shown in
Figure 5.
Fig. 5. Sensitivity Analysis of [IL-10] with respect to parameters
It is clear from Figure 5 that IL-10 production depends heavily
on β2 and β1 which is desirable as different promoter strengths
(weak, medium and strong) would enable optimisation of the
response. It can also be observed that sRNA binding rate kf
has less significant effect on the output compared to β2 and
hence, a stronger promoter would mean that a much longer
sRNA would be required to inhibit IL-10 translation. The
length of sRNA was optimised to 24 base pairs [10] yielding
∆G = −45.97Kcal ·mole−1. The graph of ∆G against the
position of base pairs is illustrated in Figure 6.
Based on the calculated ∆G, β1, β2 and k1 were set to
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Fig. 6. sRNA binding free energy variation with its base pair position
1nMmin−1, 10nMmin−1 and 100nM−1min−1 for com-
plete inhibition of IL-10 translation in the positive pathway,
in addition to a high IL-10 translation rate in negative pathway.
IV. STEADY STATE MODEL
The simplest model is an output/input, time-independent
plot which describes the system fate in response to varying
input concentrations. Secretion of IL-10 has been ignored for
steady state response as it is assumed that the system is given
ample time to settle, secreting all translated IL-10. The steady
state concentrations of species can be determined by equating
(1), (2) and (3) to zero. The steady state values for [IL-10],
[sRNA] and [IL-10 mRNA] are given below:
[IL-10 mRNA]∗ =
α2α1 + k1(Γ1 − Γ2)±
√
ω
−2α2k1 , (7)
[sRNA]∗ =
Γ1
α1 + k1[IL10 mRNA]∗
, (8)
[IL-10]∗ =
k2
α4
[IL-10 mRNA]∗, (9)
where ω =
(
k1(Γ2 − Γ1) − α1α2
)2
+ 4α1α2k1Γ2. It should
be noted that Γi denotes Hill functions for adenine and
NO. A surface can be plotted describing the output/input
steady state relation, with contours representing the steady
state characteristic of each of the pathways. The plots can
then be used for experimental fitting to obtain more realistic
parameters. The steady state surface and it’s contours could
be found in Figure 7.
V. PARAMETERS AND MODELLING PREDICTIONS FOR
CIRCUIT DESIGN
The parameters used for modelling are all listed below:
• Transcription level : β1 = 10 nM/min , β2 =
1 nM/min both optimised to give satisfactory results [4].
K1 = 300 nM [11], K2 = 10nM [4].
• Translation level : k1 = 100 min−1 optimised based on
the number of base pairs in sRNA. k2 = 0.3 min−1 is
the translation rate of IL-10 [4].
• Degradation and Diffusion : α1 = 0.03 min−1, α2 =
0.14 min−1, α3 = α4 = 0.03 min−1 all based on [4].
Fig. 7. The steady state surface and its contours to both of the inputs
The diffusion rate parameter was calculated based on the
number of transport proteins on the membrane of E. Coli
to be k3 = 0.13min−1 [12].
• Body response : The value of b1 and b2 were calculated
from Figure 8 and a chosen value of a = 10−4 s. b1 =
−1.6690 and b2 = 28.24.
A. Parameters range and output dependency
Three of the parameters used throughout the paper can
be tuned for optimisation, namely: β1, β2 and k1; some of
which have been previously mentioned. These parameters were
modified slightly about their optimised value to find a range
for which the system maintains a desired working state. The
optimised range for each of the parameters is given below.
1) β1 has a wide range of 8 < β1 < 90 for which a
satisfactory results could be obtained.
2) As opposed to β1, β2 has a very narrow range of
0.7 < β2 < 1.3 for which a satisfactory results could be
obtained.
3) k1 is almost saturated at the value chosen for simulation
and hence does not have an upper bound; however, there
is a lower bound of 1 < k1 for which a satisfactory result
can be obtained.
Equations 7 - 9 can be differentiated to find the dependency of
IL-10 with respect to all three tunable parameters. As [IL10]∗
depends linearly on [IL10 mRNA]∗, (7) has been differentiated
with respect to Γ1, Γ2 and k1 for simplicity. It should be noted
that since βi is the only tunable parameter in Hill functions, Γi
has been used as the parameter for simplicity in differentiation.
d[IL-10 mRNA]∗
dΓ1
=
d
dΓ1
(α2α1 + k1(Γ1 − Γ2) +√ω
−2α2k1
)
∴ = k1
2α2k1
(
1√
ω
(
k1(Γ2 − Γ1)− α1α2
)− 1), (10)
d[IL-10 mRNA]∗
dΓ2
=
d
dΓ2
(α2α1 + k1(Γ1 − Γ2) +√ω
−2α2k1
)
∴ = k1
2α2k1
(
1− 1√
ω
(
k1(Γ2 − Γ1)− α1α2
))
, (11)
d[IL10 mRNA]∗
dk1
=
d
dk1
(α2α1 + k1(Γ1 − Γ2) +√ω
−2α2k1
)
∴ =
(
(Γ1 − Γ2) + λ
)
(−2α2k1)− 2α2µ
(−2α2k1)2 , (12)
where λ =
(
k1(Γ1−Γ2)−α1α2
)
(Γ1−Γ2
)
+4α1α2Γ2√
ω
and µ =(
α1α2 + k1(Γ1 − Γ2) +
√
ω
)
. Based on (10), (11) and (12),
the dependency of IL-10 with respect to β1, β2 and k1 is
clear. The expression k1(Γ2−Γ1)−α1α2 is less than
√
ω and
therefore it could be concluded that:
1) d[IL-10 mRNA]
∗
dΓ1
< 0
2) d[IL-10 mRNA]
∗
dΓ2
> 0
3) d[IL-10 mRNA]
∗
dk1
< 0
β1 and k1 are both in the inhibitory pathway as opposed to
β2 and hence, all three statements above validate the model.
B. Modelling predictions for circuit design
Based on the range and dependency of [IL-10] on different
parameters, a medium strength promoter is suggested to be
used for negative pathway as opposed to positive pathway
where either a strong promoter or a medium strength promoter
with a high copy number is suggested. As for the length of
sRNA, it was shown that as long as it has just a few base pairs,
corresponding to k1 = 1, the output would not be affected
significantly and hence, the most energetically feasible length
is used.
VI. BODY DYNAMICS
The response of the body is crucial to obtain comprehensive
model reflecting systemic interactions between the engineered
E. coli and the body. Body response mechanisms have been
studied in detail however due to stochastic noise, significant
assumptions were made to simplify the response for modelling.
These assumptions are summarised below; please note that
even though some of the assumptions are considerable, they
are negligible compared to the amount of variation present in
bodily systems and between individuals:
• The model is based on bulk amount of bacteria translating
or inhibiting IL-10.
• The body responds in about 3-4 hours and the response
has been taken to be linear due to lack of data points.
• The body has been assumed to behave similarly to an
LTI (Linear time-invariant) system and the model can be
extrapolated, with care, for people with different body
responses.
Based on assumptions stated above, two lines can be plotted
for elevated levels of NO and Adenosine versus IL-10 - the
highest and lowest concentration of IL-10 [13] and its corre-
sponding signalling molecule [6] [8] that has been measured in
human body. The plot of steady-state concentrations is shown
in Figure 8.
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Fig. 8. Linear approximation for steady-state body response in both reaction
pathways
The dynamic response of the body is assumed to be linear
with a response time of about 3 hours(104s) as very few data
points were available for the steady state response of the body.
Therefore, the differential equation describing the response is
as follows:
d[NO,Adenine]
dt
= −ai[NO,Adenine] + bi[IL10] + ci, (13)
Figure 8 can be used to find ba and
c
a for both positive
and negative pathways. Then by choosing a = 10−4s−1, for
the response time, (13) is fully defined and can be solved
simultaneously with (1) - (4) to give an overall prediction on
how the body and the probiotic bacteria would interact with
each other to reach an equilibrium concentration of IL-10 in
the body. It should be noted that for these two to be solved
together, one should be aware of the correction factor required
to approximate metabolite concentrations inside a bacterium
relative to the body, in addition to an indication of the number
of bacteria being used. Hence, the initial number of bacteria
is optimised in a correction loop by looking at the settle time
of IL-10 inside the body. The dynamics of IL-10 in the body
for elevated level of NO and adenine are shown in Figures 9
and 10 respectively. It should be noted that for representation
purposes, the concentration of IL-10 in the body - magenta
dashed line - has been multiplied by 106.
It is clear from Figures above that the body and E. Coli reach a
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Fig. 9. E. Coli - Body dynamic response to elevated level of NO
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Fig. 10. E. Coli - Body dynamic response to elevated level of adenine
stable concentration of IL-10 without oscillation in any of the
metabolite concentrations. The accuracy of the response time
of 104 seconds is reflected by the similarity of the steady-state.
The number of E Coli used for simulation would significantly
affect the settle time or the response time and hence, the time
taken by the combined system to reach 90% of the steady-state
concentration of IL-10 has been plotted against the number
of bacteria in Figure 11. It is essential to understand the
significance and importance of the positive pathway in stability
and robustness of the proposed probiotic. Hence, dynamics of
the combined system has been plotted in absence of Adenine
pathway to demonstrate that the system becomes unstable
without a negative feedback loop.
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Fig. 11. 90 % Settle Time - Number of E Coli used for Simulation
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Fig. 12. Unstable system in the absence of the inhibiting pathway
VII. NEGATIVE FEEDBACK AND FREQUENCY DOMAIN
ANALYSIS
As discussed earlier in the paper, both positive and negative
feedback could potentially correct the concentration of IL-
10 in the body. However, it is important to note that body
response should be included in the model to give an actual
and meaningful prediction of how E. coli would behave in
the body. For this purpose, control theory and the negative
feedback loop have been used by transforming the body
and the bacteria in a standard cascade compensation model
and deriving their transfer functions. Hence, we developed a
cascade compensation model where we have the body as the
plant and the bacteria as the controller. Assumptions made for
frequency domain analysis are listed below:
• The system has been linearised about an equilibrium point
and therefore, it has been assumed that perturbations are
small for the Taylor series to converge.
• The reaction pathways will be analysed separately as
based on superposition, the response of the linearised
model would be a sum of its response to inputs separately.
• Secretion has been ignored for simplicity in transfer
function.
Therefore, by using the correct transfer function, both models
would fall into the same control design, just with different
transfer functions. The proposed design for the feedback loop
could be seen in Figure 13.
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Fig. 13. Cascade compensation design
The aim of the controller is to set the reference signal,
namely NO and adenosine, to nominal level as this would
correspond to a healthy concentration of IL-10 within the body.
Transfer functions for the controller- both positive and negative
pathway- and the body are required for control analysis of
system response in a human body.
VIII. TRANSFER FUNCTIONS
As stated in the assumptions, the model has been linearised
due to non-linearity raised by the Hill functions and sRNA
binding. Therefore, Hill functions have been replaced by γ∗i as
stated earlier in Equation 6. The block diagram and signal flow
graph for the linearised system are shown in Figures 14 and
15, where transcription of IL-10 mRNA, sRNA and translation
of IL-10 can be seen clearly.
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Fig. 14. Block diagram in frequency domain for linearised model
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Fig. 15. Signal Flow Graph(SFG) for the linearised model
Transfer functions for both negative and positive pathways
were found using Mason’s gain relation [14] and confirmed
against [4]. Transfer functions of both positive and negative
pathways can be found below:
G1(s) =
IL10(s)
Adenine(s)
=
k2γ
∗
1(s+ α1 + k1[IL10 mRNA]
∗)
(s+ α3)(s+ s+)(s+ s−)
,
(14)
G2(s) =
IL10(s)
NO(s)
=
−k1[IL10 mRNA]∗k2γ∗2
(s+ α3)(s+ s+)(s+ s−)
, (15)
where s± = 12 (α2 + k1[sRNA]
∗ + α1 + k1[IL10 mRNA]∗)±
1
2
√
d and d = (α2 + k1[sRNA]∗−α1− k1[IL10 mRNA]∗)2 +
4k21[IL10 mRNA]
∗[sRNA]∗.
A. Body response transfer function
Laplace transform can be taken from both sides of the Equa-
tion 13 and by ignoring c, being very small and negligible, the
transfer function for the body can be derived:
s[NO,Adenine(s)] = −ai[NO,Adenine(s)] + bi[IL10(s)]
=⇒ Fi(s) = [NO,Adenine(s)]
[IL10(s)]
=
bi
s+ ai
(16)
IX. STABILITY
The closed loop transfer function for cascade cascade con-
troller design given in Figure 13 would contain important
information regarding steady state error and relative stability.
It should be mentioned that similar to most control problems
where the controller is designed for specific specifications [15],
the reaction pathway can be changed by altering promoter
strength and sRNA length, making it almost possible to adopt
desired structures for the controller. The closed loop transfer
function for positive and negative pathways is as follows:
Ti(s) =
Fi(s)Gi(s)
1 + Fi(s)Gi(s)
(17)
Based on (17), the stability of the system can be determined
by observing the location of the poles which are roots of the
characteristic polynomial 1 + Fi(s)Gi(s) = 0. The character-
istic equation for adenine and NO reference signals is given
in Equations 18 and 19.
1 +
k2γ
∗
1 (s+ α1 + k1[IL10 mRNA]
∗)
(s+ α3)(s+ s+)(s+ s−)
· b1
s+ a1
= 0 (18)
1 +
−k1[IL10 mRNA]∗k2γ∗2
(s+ α3)(s+ s+)(s+ s−)
· b2
s+ a2
= 0 (19)
Equations (18) and (19) were solved numerically [16] and
smallest poles and zeros for both reaction pathways are
summarised in the Argand diagram below, Figure 16. All poles
and Zeros are summarised after the figure.
Fig. 16. poles and zeros for NO and Adenine responses
It should be noted that some poles and zeros were not plotted
as they were significantly larger(in magnitude) than those
shown in Figure 16 and would have thus hindered comparison
with those illustrated. All poles and zeros are given below.
1) NO response :
• Poles : s1 ≈ −1.075 × 104 , s2 ≈ −0.030 , s3 ≈
−0.030 and s4 ≈ 1.060× 104.
• Zeros : z1 = 1.075 × 104, z2 = −0.030, z3 =
−0.030, z4 = 1.000× 10−4.
2) Adenine response :
• Poles : s1 ≈ 50.656, s2 ≈ 0.474, s3 ≈ 0.474 and
s4 =≈ 0.262.
• Zeros : z1 = 50.656, z2 = 50.000, z3 = 0.656,
z4 = 1.000× 104.
Despite right-plane poles, it should be noted that both re-
sponses can be considered stable as the dominant poles are
significantly larger- in magnitude- than all other poles.
X. STEADY STATE ERROR - DC GAIN
E(s) =
1
1 +Gi(s)Fi(s)
R(s) , R(s) =
C
s
C ∈ R
FV T : lim
t→∞ e(t) = lims→0
sE(s)
∴ lim
t→∞ e(t) = lims→0
1
1 +Gi(s)Fi(s)
(20)
By substituting back Transfer functions for both E. Coli,Gi(s),
and the body,Fi(s), the steady state error can be found as
follows:
• For NO response limt→∞ e(t) = −2.9501× 10−4.
• For adenine response limt→∞ e(t) = −2.1912× 10−3.
It is evident that the combined model has a very small DC
gain and hence, a very small margin of error is estimated for
the steady concentration of IL-10.
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